Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Self-reported levels of education and disability progression in multiple sclerosis.
Urban traffic-derived nanoparticulate matter reduces neurite outgrowth via TNFα in vitro.
Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies.
DNA damage in the oligodendrocyte lineage and its role in brain aging.
APE1/Ref-1 facilitates recovery of gray and white matter and neurological function after mild stroke injury.
Loss of Hippocampal Oligodendrocytes Contributes to the Deficit of Contextual Fear Learning in Adult Rats Experiencing Early Bisphenol A Exposure.
Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4).
Improving the management of chronic inflammatory demyelinating polyradiculoneuropathy.
Antigen dynamics govern the induction of CD4(+) T cell tolerance during autoimmunity.
High Intensity Training May Reverse the Fiber Type Specific Decline in Myogenic Stem Cells in Multiple Sclerosis Patients.
Why use sex hormones in relapsing-remitting multiple sclerosis? - Authors' reply.
Influenza vaccination in patients with multiple sclerosis is possible with some considerations.
Enhancement of aptamer immobilization using egg shell-derived nano-sized spherical hydroxyapatite for thrombin detection in neuroclinic.
The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®.
Malignant chondroid syringoma in a West African cancer institute: A case report.
Neurosarcoidosis in Pediatric Patients: A Case Report and Review of Isolated and Systemic Neurosarcoidosis.
Etiological, clinical, and radiological features of longitudinally extensive myelopathy in Chinese patients.
Aescin reduces oxidative stress and provides neuroprotection in experimental traumatic spinal cord injury.
Assessment of severity of neurogenic bowel dysfunction in chronic patients with a simple 1-item questionnaire (PGI-S).
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.
HLA Genetic Risk Burden in Multiple Sclerosis.
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
Asymptomatic central pontine myelinolysis without hyponatriemia in diffuse large B cell lymphoma.
Nanocarriers as Tools in Delivering Active Compounds for Immune System Related Pathologies.

Pages